BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harrison CJ. Changes in treatment strategies for acute otitis media after full implementation of the pneumococcal seven valent conjugate vaccine. Pediatr Infect Dis J 2003;22:S120-30. [PMID: 14566998 DOI: 10.1097/00006454-200308001-00003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Block SL, Doern GV, Pfaller MA. Oral β-lactams in the treatment of acute otitis media. Diagnostic Microbiology and Infectious Disease 2007;57:S19-30. [DOI: 10.1016/j.diagmicrobio.2007.01.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Casey JR, Pichichero ME. Changes in Frequency and Pathogens Causing Acute Otitis Media in 1995–2003. Pediatric Infectious Disease Journal 2004;23:824-8. [DOI: 10.1097/01.inf.0000136871.51792.19] [Cited by in Crossref: 312] [Cited by in F6Publishing: 260] [Article Influence: 17.3] [Reference Citation Analysis]
3 Perez Vidakovics ML, Riesbeck K. Virulence mechanisms of Moraxella in the pathogenesis of infection. Curr Opin Infect Dis 2009;22:279-85. [PMID: 19405217 DOI: 10.1097/qco.0b013e3283298e4e] [Cited by in Crossref: 37] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
4 Johnson DM, Stilwell MG, Fritsche TR, Jones RN. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999–2003). Diagnostic Microbiology and Infectious Disease 2006;56:69-74. [DOI: 10.1016/j.diagmicrobio.2005.12.008] [Cited by in Crossref: 62] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
5 Mitropoulos IF, Rotschafer JC, Rodvold KA. Adverse events associated with the use of oral cephalosporins/cephems. Diagnostic Microbiology and Infectious Disease 2007;57:S67-76. [DOI: 10.1016/j.diagmicrobio.2006.12.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
6 Gené A, García-García JJ, Domingo A, Wienberg P, Palacín E. [Etiology of acute otitis media in a children's hospital and antibiotic sensitivity of the bacteria involved]. Enferm Infecc Microbiol Clin 2004;22:377-80. [PMID: 15355766 DOI: 10.1016/s0213-005x(04)73119-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Tan TT, Riesbeck K. Current progress of adhesins as vaccine candidates for Moraxella catarrhalis. Expert Rev Vaccines 2007;6:949-56. [PMID: 18377357 DOI: 10.1586/14760584.6.6.949] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
8 Fallon RM, Kuti JL, Doern GV, Girotto JE, Nicolau DP. Pharmacodynamic Target Attainment of Oral β-Lactams for the Empiric Treatment of Acute Otitis Media in Children: . Pediatric Drugs 2008;10:329-35. [DOI: 10.2165/00148581-200810050-00006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
9 Zacharisen M, Casper R. Pediatric sinusitis. Immunol Allergy Clin North Am 2005;25:313-32, vii. [PMID: 15878458 DOI: 10.1016/j.iac.2005.02.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
10 Sabirov A, Metzger DW. Mouse models for the study of mucosal vaccination against otitis media. Vaccine 2008;26:1501-24. [PMID: 18295938 DOI: 10.1016/j.vaccine.2008.01.029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
11 Regelmann WE. A Pain in the Ear: What Has the 7-Valent Conjugated Pneumococcal Vaccine Done to Reduce the Incidence of Acute Otitis Media? Clinical Infectious Diseases 2005;40:1745-7. [DOI: 10.1086/429925] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
12 Sabirov A, Metzger DW. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media. Vaccine 2006;24:5584-92. [PMID: 16730398 DOI: 10.1016/j.vaccine.2006.04.033] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
13 Pichichero ME, Casey JR. Evolving Microbiology and Molecular Epidemiology of Acute Otitis Media in the Pneumococcal Conjugate Vaccine Era. Pediatric Infectious Disease Journal 2007;26:S12-6. [DOI: 10.1097/inf.0b013e318154b25d] [Cited by in Crossref: 38] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
14 Murphy TF, Bakaletz LO, Kyd JM, Watson B, Klein DL. Vaccines for otitis media: proposals for overcoming obstacles to progress. Vaccine 2005;23:2696-702. [PMID: 15780715 DOI: 10.1016/j.vaccine.2004.12.014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
15 Wang MC, Wang YP, Chu CH, Tu TY, Shiao AS, Chou P. Impact of pneumococcal conjugate vaccine on pediatric tympanostomy tube insertion in partial immunized population. ScientificWorldJournal 2015;2015:248678. [PMID: 25839052 DOI: 10.1155/2015/248678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]